Document:

AGREEMENT

 

FOR
THE EXCHANGE OF SECURITIES

 

BY
AND AMONG

 

VALMIE
RESOURCES, INC.

(A
NEVADA CORPORATION)

 

and

 

VERTITEK,
INC.

(A
WYOMING CORPORATION)

 

AND

 

the
shareholder of

VERTITEK,
INC.

 

    	i

    	 

    

 

INDEX

 

	 	Page
	Cover
    page	i
	 	 	 
	ARTICLE
    I – Exchange of Securities	1
	 	 	 
	Exchange
    of Securities	1
	 	 	 
	1.1	Issuance of
    Securities	1
	1.2	Exemption from
    Registration	1
	 	 	 
	ARTICLE
    II – Representations and Warranties of VERTITEK, INC.	1
	 	 	 
	Representations
    and Warranties of VERTITEK, INC.	1
	2.1	Organization	2
	2.2	Capital	2
	2.3	Subsidiaries	2
	2.4	Directors and
    Executive Officers	2
	2.5	Financial Statements	2
	2.6	Absence of
    Changes	2
	2.7	Absence of
    Undisclosed Liabilities	2
	2.8	RESERVED	3
	2.9	Investigation
    of Financial Condition	3
	2.10	Intellectual
    Property Rights	3
	2.11	Compliance
    with Laws	3
	2.12	Litigation	3
	2.13	Authority	3
	2.14	Ability to
    Carry Out Obligations	3
	2.15	Full Disclosure	4
	2.16	Assets	4
	2.17	Indemnification	4
	2.18	Criminal or
    Civil Acts	4
	2.19	Restricted
    Securities	4
	 	 	 
	ARTICLE
    III – Representations and Warranties of VALMIE RESOURCES, INC.	4
	 	 	 
	Representations
    and Warranties of VALMIE RESOURCES, INC.	4
	3.1	Organization	4
	3.2	Capital	4
	3.3	Subsidiaries	5
	3.4	Directors and
    Officers	5
	3.5	Financial Statements	5
	3.6	Absence of
    Changes	5
	3.7	Absence of
    Undisclosed Liabilities	5
	3.8	RESERVED	6
	3.9	Investigation
    of Financial Condition	6
	3.10	Intellectual
    Property Rights	6

 

    	ii

    	 

    

 

 

	3.11	Compliance
    with Laws	6
	3.12	Litigation	6
	3.13	Authority	6
	3.14	Ability to
    Carry Out Obligations	6
	3.15	Full Disclosure	6
	3.16	Assets	7
	3.17	Indemnification	7
	3.18	Criminal or
    Civil Acts	7
	 	 	 
	ARTICLE
    IV – Covenants Prior to the Closing Date	7
	 	 	 
	Covenants
    Prior to the Closing Date	7
	4.1	Investigative
    Rights	7
	4.2	Conduct of
    Business	7
	4.3	Confidential
    Information	7
	4.4	Notice of Non-Compliance	8
	 	 	 
	ARTICLE
    V – Conditions Precedent to VALMIE RESOURCES, INC. Performance	8
	 	 	 
	Conditions
    Precedent to VALMIE RESOURCES, INC. Performance	8
	5.1	Conditions	8
	5.2	Accuracy of
    Representations	8
	5.3	Performance	8
	5.4	Absence of
    Litigation	8
	5.5	Corporate Action	8
	5.6	Acceptance
    of Financial Statements	8
	 	 	 
	ARTICLE
    VI – Conditions Precedent to VERTITEK, INC. Performance	8
	 	 	 
	Conditions
    Precedent to VERTITEK, INC. Performance	8
	6.1	Conditions	8
	6.2	Accuracy of
    Representations	9
	6.3	Performance	9
	6.4	Absence of
    Litigation	9
	6.5	Acceptance
    of Financial Statements	9
	 	 	 
	ARTICLE
    VII – Closing	9
	 	 	 
	Closing	9
	7.1	Closing	9
	 	 	 
	ARTICLE
    VIII – Reserved	9
	 	 	 
	ARTICLE
    IX – Miscellaneous	10
	 	 	 
	Miscellaneous	10
	9.1	Captions and
    Headings	10
	9.2	No Oral Change	10

 

    	iii

    	 

    

 

	9.3	Non-Waiver	10
	9.4	Time of Essence	10
	9.5	Entire Agreement	10
	9.6	Choice of Law	10
	9.7	Counterparts	10
	9.8	Notices	10
	9.9	Binding Effect	11
	9.10	Mutual Cooperation	11
	9.11	Finders / Brokers	11
	9.12	Announcements	11
	9.13	Expenses	11
	9.14	Survival of
    Representations and Warranties	11
	9.15	Exhibits	11
	9.16	Termination,
    Amendment and Waiver	11

 

EXHIBITS

 

	Subscription Agreement	Exhibit
    1.1
	Financial Statements
    of VERTITEK, INC.	Exhibit
    2.5
	Financial Statements
    of VALMIE RESOURCES, INC.	Exhibit
    3.5

 

    	iv

    	 

    

 

AGREEMENT

 

THIS
AGREEMENT (“Agreement”) is made as of January 27, 2015, by and among VALMIE
RESOURCES, INC., a Nevada corporation (“VMRI” or the “Company”),
VERTITEK, INC., a Wyoming corporation (“VERTITEK”),
and MASAMOS SERVICES LTD., the registered holder of 100% of the issued and outstanding equity shares of VERTITEK
(the “SHAREHOLDER”).

 

WHEREAS,
VMRI desires to acquire all of the issued and outstanding common stock of VERTITEK from the SHAREHOLDER in
exchange for newly issued unregistered shares of common stock of VMRI; and

 

WHEREAS,
VERTITEK desires to assist VMRI in acquiring all of the issued and outstanding shares of VERTITEK pursuant
to the terms of this Agreement; and

 

WHEREAS,
the SHAREHOLDER desires to exchange 100% of the issued and outstanding equity shares of VERTITEK held by SHAREHOLDER
(the “Vertitek Shares”) for 1,000,000 shares of the Company’s common stock (the “Purchase
Shares”). Such Purchase Shares to be issued to the SHAREHOLDER in exchange for the Vertitek Shares
(as hereinafter defined).

 

NOW,
THEREFORE, in consideration of the mutual promises, covenants and representations contained herein, the parties hereto agree as
follows:

 

ARTICLE
I

Exchange
of Securities

 

1.1
Issuance of Securities. Subject to the terms and conditions of this Agreement, VMRI agrees to issue and exchange
the Purchase Shares for the Vertitek Shares. Upon the Closing Date of this Agreement (the “Closing
Date”), the Board of Directors of VMRI (the “Board”) shall direct that the Purchase Shares
of VMRI be issued as set forth in Article 1.1 hereof.

 

1.2
Exemption from Registration. The parties hereto intend that all VMRI common shares to be issued to the SHAREHOLDER
shall be exempt from the registration requirements of the Securities Act of 1933, as amended (the “Act”), pursuant
to Section 4(2) and/or Section 506 of Regulation D of the Act and rules and regulations promulgated there under. In furtherance
thereof, the SHAREHOLDER will execute and deliver to VMRI on the Closing Date a subscription agreement formalizing
this exchange.

 

ARTICLE
II

Representations
and Warranties of VERTITEK and the SHAREHOLDER

 

VERTITEK
and the SHAREHOLDER hereby represent and warrant to VMRI that:

 

    	1

    	 

    

 

2.1
Organization. VERTITEK is a corporation duly organized, validly existing and in good standing under the laws of
Wyoming, has all necessary corporate powers to own its properties and to carry on its business as now owned and operated by it,
and is duly qualified to do business and is in good standing in each of the states where its business requires qualification.

 

2.2
Capital. There are an aggregate of 1,000,000 shares of VERTITEK shares issued and outstanding. There are no outstanding
subscriptions, options, rights, warrants, debentures, instruments, convertible securities or other agreements or commitments obligating
VERTITEK to issue any additional VERTITEK shares of any class.

 

2.3
Subsidiaries. VERTITEK does not have any subsidiaries or own any interest in any other enterprise.

 

2.4
Directors and Executive Officers. The names and titles of the directors and executive officers of VERTITEK are as
follows:

 

	Name	 	Position
	 	 	 
	Sean
    Foster	 	Sole
    Officer / Director

 

2.5
Financial Statements. On or before the Closing Date, VERTITEK shall provide VMRI with financial statements
of VERTITEK for the period from Incorporation (February 19, 2014) to January 31, 2015 (the “VERTITEK Financial
Statements”). The financial statements are attached hereto as Exhibit 2.5. VERTITEK’s Financial
Statements shall be prepared in accordance with generally accepted accounting principles and practices consistently followed by
VERTITEK throughout the period indicated, and fairly present the financial position of VERTITEK as of the date of
the balance sheet included in the VERTITEK Financial Statements and the results of operations for the period indicated.

 

2.6
Absence of Changes. Since the Due Diligence review of VERTITIEK was completed, there has not been any material change
in the financial condition or operations of VERTITEK. As used throughout this Agreement, “material” means:
Any change or effect (or development that, insofar as can be reasonably foreseen, is likely to result in any change or effect)
that causes substantial increase or diminution in the business, properties, assets, condition (financial or otherwise) or results
of operations of a party. Taken as a whole, material change shall not include changes in national or international economic conditions
or industry conditions generally; changes or possible changes in statutes and regulations applicable to a party; or the loss of
employees, customers or suppliers by a party as a direct or indirect consequence of any announcement relating to this transaction.

 

2.7
Absence of Undisclosed Liabilities. As of the date of execution hereof, VERTITEK did not have any material debt,
liability or obligation of any nature, whether accrued, absolute, contingent or otherwise, and whether due or to become due, that
is not reflected in the VERTITEK Financial Statements.

 

    	2

    	 

    

 

2.8
RESERVED

 

2.9
Investigation of Financial Condition. Without in any manner reducing or otherwise mitigating the representations contained
herein, VMRI, its legal counsel and accountants shall have the opportunity to meet with VERTITEK’s accountants
and attorneys to discuss the financial condition of VERTITEK during reasonable business hours and in a manner that does
not interfere with the normal operation of VERTITEK’s business. VERTITEK shall make available to VMRI
all books and records of VERTITEK.

 

2.10
Intellectual Property Rights. VERTITEK owns or has the right to use all trademarks, service marks, trade names,
copyrights and patents material to its business.

 

2.11
Compliance with Laws. To the best knowledge of VERTITEK and the SHAREHOLDER, VERTITEK has complied
with, and is not in violation of, applicable federal, state or local statutes, laws and regulations, including federal and state
securities laws, except where such non-compliance would not have a material adverse impact upon its business or properties.

 

2.12
Litigation. VERTITEK is not a defendant in any suit, action, arbitration or legal, administrative or other proceeding,
or governmental investigation which is pending or, to the best knowledge of VERTITEK, threatened against or affecting VERTITEK
or its business, assets or financial condition. VERTITEK is not in default with respect to any order, writ, injunction
or decree of any federal, state, local or foreign court, department, agency or instrumentality applicable to it. VERTITEK
is not engaged in any material litigation to recover monies due to it.

 

2.13
Authority. The Board of Directors of VERTITEK has authorized the execution of this Agreement and the consummation
of the transactions contemplated herein, and VERTITEK has full power and authority to execute, deliver and perform this
Agreement, and this Agreement is a legal, valid and binding obligation of VERTITEK and is enforceable in accordance with
its terms and conditions. SHAREHOLDER has agreed to and has approved the terms of this Agreement and the exchange of securities
contemplated hereby.

 

2.14
Ability to Carry Out Obligations. The execution and delivery of this Agreement by VERTITEK and the SHAREHOLDER
and the performance by VERTITEK and the SHAREHOLDER of their obligations hereunder in the time and manner contemplated
will not cause, constitute or conflict with or result in (a) any breach or violation of any of the provisions of or constitute
a default under any license, indenture, mortgage, instrument, article of incorporation, bylaw, or other agreement or instrument
to which VERTITEK is a party, or by which it may be bound, nor will any consents or authorizations of any party other than
those hereto be required, (b) an event that would permit any party to any agreement or instrument to terminate it or to accelerate
the maturity of any indebtedness or other obligation of VERTITEK, or (c) an event that would result in the creation or
imposition of any lien, charge or encumbrance on any asset of VERTITEK.

 

    	3

    	 

    

 

2.15
Full Disclosure. None of the representations and warranties made by VERTITEK or the SHAREHOLDER herein or
in any exhibit, certificate or memorandum furnished or to be furnished by VERTITEK, or on its behalf, contains or will
contain any untrue statement of material fact or omit any material fact the omission of which would be misleading.

 

2.16
Assets. VERTITEK’s assets are fully included in Exhibit 2.5 and are not subject to any claims or encumbrances
except as indicated in Exhibit 2.5.

 

2.17
Indemnification. VERTITEK and the SHAREHOLDER agree to indemnify, defend and hold VMRI harmless against and
in respect of any and all claims, demands, losses, costs, expenses, obligations, liabilities, damages, recoveries and deficiencies,
including interest, penalties and reasonable attorney fees asserted by third parties against VMRI which arise out of, or
result from (i) any breach by VERTITEK or the SHAREHOLDER in performing any of its covenants or agreements under
this Agreement or in any schedule, certificate, exhibit or other instrument furnished or to be furnished by VERTITEK or
the SHAREHOLDER under this Agreement, (ii) a failure of any representation or warranty in this Article II or (iii) any
untrue statement made by VERTITEK or the SHAREHOLDER in this Agreement.

 

2.18
Criminal or Civil Acts. For the period of five years prior to the execution of this Agreement, no executive officer,
director or principal stockholder of VERTITEK has been convicted of a felony crime, been the subject of a Securities and
Exchange Commission (the “Commission”) or National Association of Securities Dealers (the “NASD”) judgment
or decree, or is currently the subject to any investigation in connection with a Commission or NASD proceeding.

 

2.19
Restricted Securities. VERTITEK and the SHAREHOLDER acknowledge that all of the VMRI shares issued
by VMRI pursuant to Article 1.1 hereof are restricted securities and none of such securities may be sold or publicly traded
except in accordance with the provisions of the Securities Act of 1933, as amended (the “Act”).

 

ARTICLE
III

Representations
and Warranties of VMRI

 

VMRI
represents and warrants to VERTITEK that:

 

3.1
Organization. VMRI is a corporation duly organized, validly existing and in good standing under the laws of Nevada,
has all necessary corporate powers to carry on its business, and is duly qualified to do business and is in good standing in each
of the states where its business requires qualification.

 

3.2
Capital. The authorized shares of VMRI consists of (i) 750,000,000 shares of common stock, $0.001 par value, of
which 59,040,000 shares are issued and outstanding as of the Closing Date; and (ii) 10,000,000 shares of preferred stock,
$0.001 par value, of which 2,000,000 shares are issued and outstanding as of the Closing Date.

 

    	4

    	 

    

 

Following
the issuance of the Purchase Shares as set forth in Article 1.1 hereof, there shall be a total of (i) 60,040,000 shares
of common stock of the Company issued and outstanding; and (ii) 2,000,000 shares of the preferred stock issued and outstanding.

 

All
of the outstanding common shares prior to the entering into this Agreement are, and all of the Purchase Shares to be issued
as set forth in Article 1.1 hereof, shall be duly and validly issued, fully paid and non-assessable. Other than as set forth herein,
there are no outstanding subscriptions, options, rights, warrants, debentures, instruments, convertible securities or other agreements
or commitments obligating VMRI to issue any additional shares of any class.

 

3.3
Subsidiaries. VMRI does not have any subsidiaries or own any interest in any other enterprise.

 

3.4
Directors and Officers. The name and title of the director(s) and executive officer(s) of VMRI are as follows:

 

	Name	 	Position
	 	 	 
	Gerald
    Hammack	 	Chairman
    & Chief Executive Officer

 

3.5
Financial Statements. On or before the Closing Date, VMRI shall file with the Securities and Exchange Commission
its annual report on Form 10-K which shall include the audited financial statements of VMRI for the two fiscal years ended
November 30, 2014 and November 30, 2013 (the “VMRI Financial Statements”). The VMRI Financial
Statements will be prepared in accordance with generally accepted accounting principles and practices consistently followed
by VMRI throughout the periods indicated, and fairly present the financial position of VMRI as of the date of the
balance sheets included in the VMRI Financial Statements and the results of operations for the periods indicated.

 

3.6
Absence of Changes. Since November 30, 2014, there has not been any undisclosed material change in the financial condition
or operations of VMRI. As used throughout this Agreement, “material” means: Any change or effect (or development
that, insofar as can be reasonably foreseen, is likely to result in any change or effect) that causes substantial increase or
diminution in the business, properties, assets, condition (financial or otherwise) or results of operations of a party. Taken
as a whole, material change shall not include changes in national or international economic conditions or industry conditions
generally; changes or possible changes in statutes and regulations applicable to a party; or the loss of employees, customers
or suppliers by a party as a direct or indirect consequence of any announcement relating to this transaction.

 

3.7
Absence of Undisclosed Liabilities. As of the date of execution hereof, VMRI did not have any material debt, liability
or obligation of any nature, whether accrued, absolute, contingent or otherwise, and whether due or to become due, that is not
reflected in the VMRI Financial Statements.

 

    	5

    	 

    

 

3.8
RESERVED

 

3.9
Investigation of Financial Condition. Without in any manner reducing or otherwise mitigating the representations contained
herein, VERTITEK, its legal counsel and accountants shall have the opportunity to meet with VMRI’s accountants
and attorneys to discuss the financial condition of VMRI during reasonable business hours and in a manner that does not
interfere with the normal operation of VMRI’s business. VMRI shall make available to VERTITEK all books
and records of VMRI.

 

3.10
Intellectual Property Rights. VMRI has no trademarks, service marks, trade names, copyrights or patents material
to its business.

 

3.11
Compliance with Laws. To the best of VMRI’s knowledge, VMRI has complied with, and is not in violation
of, applicable federal, state or local statutes, laws and regulations, including federal and state securities laws, except where
such non-compliance would not have a material adverse impact upon its business or properties.

 

3.12
Litigation. VMRI is not a defendant in any suit, action, arbitration or legal, administrative or other proceeding,
or governmental investigation which is pending or, to the best knowledge of VMRI, threatened against or affecting VMRI
or its business, assets or financial condition. VMRI is not in default with respect to any order, writ, injunction
or decree of any federal, state, local or foreign court, department, agency or instrumentality applicable to it. VMRI is
not engaged in any material litigation to recover monies due to it.

 

3.13
Authority. The Board of VMRI has authorized the execution of this Agreement and the consummation of the transactions
contemplated herein, and VMRI has full power and authority to execute, deliver and perform this Agreement, and this Agreement
is a legal, valid and binding obligation of VMRI and is enforceable in accordance with its terms and conditions.

 

3.14
Ability to Carry Out Obligations. The execution and delivery of this Agreement by VMRI and the performance by VMRI
of its obligations hereunder in the time and manner contemplated will not cause, constitute or conflict with or result in
(a) any breach or violation of any of the provisions of or constitute a default under any license, indenture, mortgage, instrument,
article of incorporation, bylaw, or other agreement or instrument to which VMRI is a party, or by which it may be bound,
nor will any consents or authorizations of any party other than those hereto be required, (b) an event that would permit any party
to any agreement or instrument to terminate it or to accelerate the maturity of any indebtedness or other obligation of VMRI,
or (c) an event that would result in the creation or imposition of any lien, charge or encumbrance on any asset of VMRI.

 

3.15
Full Disclosure. None of the representations and warranties made by VMRI herein or in any exhibit, certificate or
memorandum furnished or to be furnished by VMRI, or on its behalf, contains or will contain any untrue statement of material
fact or omit any material fact the omission of which would be misleading.

 

    	6

    	 

    

 

3.16
Assets. VMRI assets are fully included in the VMRI Financial Statements and are not subject to any claims
or encumbrances except as indicated in the VMRI Financial Statements.

 

3.17
Indemnification. VMRI agrees to indemnify, defend and hold VERTITEK and the SHAREHOLDER harmless against
and in respect of any and all claims, demands, losses, costs, expenses, obligations, liabilities, damages, recoveries and deficiencies,
including interest, penalties and reasonable attorney fees asserted by third parties against VERTITEK or the SHAREHOLDER
which arise out of, or result from (i) any breach by VMRI in performing any of its covenants or agreements under this
Agreement or in any schedule, certificate, exhibit or other instrument furnished or to be furnished by VMRI under this
Agreement, (ii) a failure of any representation or warranty in this Article III or (iii) any untrue statement made by VMRI
in this Agreement.

 

3.18
Criminal or Civil Acts. For the period of five years prior to the execution of this Agreement, no executive officer,
director or principal stockholder of VMRI has been convicted of a felony crime, been the subject of a Commission or NASD
judgment or decree, or is currently the subject to any investigation in connection with a Commission or NASD proceeding.

 

ARTICLE
IV

Covenants
Prior to the Closing Date

 

4.1
Investigative Rights. Prior to the Closing Date, each party shall provide to the other party, and such other party’s
counsel, accountants, auditors and other authorized representatives, full access during normal business hours and upon reasonable
advance written notice to all of each party’s properties, books, contracts, commitments and records for the purpose of examining
the same. Each party shall furnish the other party with all information concerning each party’s affairs as the other party
may reasonably request. If, during the investigative period one party learns that a representation of the other party was not
accurate, no such claim may be asserted by the party so learning that a representation of the other party was not accurate.

 

4.2
Conduct of Business. Prior to the Closing Date, each party shall conduct its business in the normal course and shall
not sell, pledge or assign any assets without the prior written approval of the other party, except in the normal course of business.
Neither party shall amend its Articles of Incorporation or Bylaws (except as may be described in this Agreement), declare dividends,
redeem or sell stock or other securities. Neither party shall enter into negotiations with any third party or complete any transaction
with a third party involving the sale of any of its assets or the exchange of any of its common stock.

 

4.3
Confidential Information. Each party will treat all non-public, confidential and trade secret information received
from the other party as confidential, and such party shall not disclose or use such information in a manner contrary to the purposes
of this Agreement. Moreover, all such information shall be returned to the other party in the event this Agreement is terminated.

 

    	7

    	 

    

 

4.4
Notice of Non-Compliance. Each party shall give prompt notice to the other party of any representation or warranty
made by it in this Agreement becoming untrue or inaccurate in any respect or the failure by it to comply with or satisfy in any
material respect any covenant, condition or agreement to be complied with or satisfied by it under this Agreement.

 

ARTICLE
V 

Conditions
Precedent to VMRI’s Performance

 

5.1
Conditions. VERTITEK’s obligations hereunder shall be subject to the satisfaction at or before the Closing Date
of all the conditions set forth in this Article V. VMRI may waive any or all of these conditions in whole or in part
without prior notice; provided, however, that no such waiver of a condition shall constitute a waiver by VMRI of any other
condition of or any of VMRI’s other rights or remedies, at law or in equity, if VERTITEK shall be in default
of any of its representations, warranties or covenants under this Agreement.

 

5.2
Accuracy of Representations. Except as otherwise permitted by this Agreement, all representations and warranties by VERTITEK
in this Agreement or in any written statement that shall be delivered to VMRI by VERTITEK under this Agreement
shall be true and accurate on and as of the Closing Date as though made at that time.

 

5.3
Performance. VERTITEK shall have performed, satisfied and complied with all covenants, agreements and conditions
required by this Agreement to be performed or complied with by it on or before the Closing Date.

 

5.4
Absence of Litigation. No action, suit or proceeding, including injunctive actions, before any court or any governmental
body or authority, pertaining to the transaction contemplated by this Agreement or to its consummation, shall have been instituted
or threatened against VERTITEK on or before the Closing Date.

 

5.5
Corporate Action. VERTITEK shall have obtained the approval of the SHAREHOLDER for the transaction contemplated
by this Agreement.

 

ARTICLE
VI

Conditions
Precedent to VERTITEK’s Performance

 

6.1
Conditions. VMRI’s obligations hereunder shall be subject to the satisfaction at or before the Closing
Date of all the conditions set forth in this Article VI. VERTITEK may waive any or all of these conditions in whole
or in part without prior notice; provided, however, that no such waiver of a condition shall constitute a waiver by VERTITEK
of any other condition of or any of VERTITEK’s rights or remedies, at law or in equity, if VMRI shall
be in default of any of its representations, warranties or covenants under this Agreement.

 

6.2
Accuracy of Representations. Except as otherwise permitted by this Agreement, all representations and warranties by VMRI
in this Agreement or in any written statement that shall be delivered to VERTITEK by VMRI under this Agreement
shall be true and accurate on and as of the Closing Date as though made at that time.

 

    	8

    	 

    

 

6.3
Performance. VMRI shall have performed, satisfied and complied with all covenants, agreements and conditions required
by this Agreement to be performed or complied with by it on or before the Closing Date.

 

6.4
Absence of Litigation. No action, suit or proceeding before any court or any governmental body or authority, pertaining
to the transaction contemplated by this Agreement or to its consummation, shall have been instituted or threatened against VMRI
on or before the Closing Date.

 

6.5
Acceptance of Financial Statements. VMRI shall have reviewed and in its sole discretion accepted, prior to the Closing
Date, the VERTITEK’s Financial Statements as set forth in Exhibit 2.5.

 

ARTICLE
VII

Closing

 

7.1
Closing. The closing of this Agreement shall be held at the offices of VMRI or at any mutually agreeable place on
or prior to March 31, 2015, unless extended by mutual agreement. At the closing:

 

(a)
SHAREHOLDER shall deliver to VMRI (i) the Vertitek Shares representing 100% of the outstanding shares of
VERTITEK, (ii) an assignment of all of the VERTITEK’s shares to VMRI, and (iii) signed minutes of its
directors approving this Agreement.

 

(b)
VMRI shall deliver to SHAREHOLDER (i) certificates representing the Purchase Shares, and (ii) signed minutes
of its directors approving this Agreement.

 

ARTICLE
VIII

 

RESERVED

 

ARTICLE
IX

Miscellaneous

 

9.1
Captions and Headings. The article and Section headings throughout this Agreement are for convenience and reference only
and shall not define, limit or add to the meaning of any provision of this Agreement.

 

    	9

    	 

    

 

9.2
No Oral Change. This Agreement and any provision hereof may not be waived, changed, modified or discharged orally, but
only by an agreement in writing signed by the party against whom enforcement of any such waiver, change, modification or discharge
is sought.

 

9.3
Non-Waiver. The failure of any party to insist in any one or more cases upon the performance of any of the provisions,
covenants or conditions of this Agreement or to exercise any option herein contained shall not be construed as a waiver or relinquishment
for the future of any such provisions, covenants or conditions. No waiver by any party of one breach by another party shall be
construed as a waiver with respect to any other subsequent breach.

 

9.4
Time of Essence. Time is of the essence of this Agreement and of each and every provision hereof.

 

9.5
Entire Agreement. This Agreement contains the entire Agreement and understanding between the parties hereto and supersedes
all prior agreements and understandings.

 

9.6
Choice of Law. This Agreement and its application shall be governed by the laws of the state of Nevada.

 

9.7
Counterparts. This Agreement may be executed simultaneously in one or more counterparts, each of which shall be deemed
an original, but all of which together shall constitute one and the same instrument.

 

9.8
Notices. All notices, requests, demands and other communications under this Agreement shall be in writing and shall be
deemed to have been duly given on the date of service if served personally on the party to whom notice is to be given, or on the
third day after mailing if mailed to the party to whom notice is to be given, via facsimile or by first class mail, registered
or certified, postage prepaid, and properly addressed as follows:

 

	VERTITEK:	 	VERTITEK,
    INC.
	 	 	1712 Pioneer Ave
	 	 	Cheyenne, WY 82001
	 	 	 
	VMRI:	 	VALMIE
    RESOURCES, INC.
	 	 	999
    18th Street
	 	 	Suite 3000
	 	 	Denver, CO 80202

 

9.9
Binding Effect. This Agreement shall inure to and be binding upon the heirs, executors, personal representatives, successors
and assigns of each of the parties to this Agreement.

 

9.10
Mutual Cooperation. The parties hereto shall cooperate with each other to achieve the purpose of this Agreement and shall
execute such other and further documents and take such other and further actions as may be necessary or convenient to effect the
transaction described herein.

 

    	10

    	 

    

 

9.11
Finders/ Brokers. There are no finders or brokers in connection with this transaction.

 

9.12
Announcements. The parties will consult and cooperate with each other as to the timing and content of any public announcements
regarding this Agreement.

 

9.13
Expenses. Each party will bear their own expenses, including legal fees incurred in connection with this Agreement. The
SHAREHOLDER will not be responsible for any costs incurred in connection with the transaction contemplated by this Agreement.

 

9.14
Survival of Representations and Warranties. The representations, warranties, covenants and agreements of the parties set
forth in this Agreement or in any instrument, certificate, opinion or other writing providing for in it, shall survive the Closing
Date.

 

9.15
Exhibits. As of the execution hereof, the parties have provided each other with the exhibits described herein. Any material
changes to the exhibits shall be immediately disclosed to the other party.

 

9.16
Termination, Amendment and Waiver.

 

(a)
Termination. This Agreement may be terminated at any time prior to the Closing Date, whether before or after approval
of matters presented in connection with the share exchange by the shareholders of VMRI or by the SHAREHOLDER:

 

	 	(1)	By
    mutual written consent of VERTITEK and VMRI;
	 	 	 
	 	(2)	By
    either VERTITEK or VMRI;

 

	 	(i)	If
    any court of competent jurisdiction or any governmental, administrative or regulatory authority, agency or body shall have
    issued an order, decree or ruling or taken any other action permanently enjoining, restraining or otherwise prohibiting the
    transactions contemplated by this Agreement; or
	 	 	 
	 	(ii)	If
    the transaction shall not have been consummated on or before February 15, 2015 unless the failure to consummate the transaction
    is the result of a material breach of this Agreement by the party seeking to terminate this Agreement.

 

(3)
By VERTITEK, if VMRI breaches any of its representations or warranties hereof or fails to perform in any material
respect any of its covenants, agreements or obligations under this Agreement; and

 

(4)
By VMRI, if VERTITEK breaches any of its representations or warranties hereof or fails to perform in any material
respect any of its covenants, agreements or obligations under this Agreement.

 

    	11

    	 

    

 

(b)
Effect of Termination. In the event of termination of this Agreement by either VMRI or VERTITEK, as provided
herein, this Agreement shall forthwith become void and have no effect, without any liability or obligation on the part of VERTITEK
or VMRI, and such termination shall not relieve any party hereto for any intentional breach prior to such termination
by a party hereto of any of its representations or warranties or any of its covenants or agreements set forth in this Agreement.

 

(c)
Extension; Waiver. At any time prior to the Closing Date, the parties may, to the extent legally allowed, (a) extend
the time for the performance of any of the obligation of the other acts of the other parties, (b) waive any inaccuracies in the
representations and warranties contained herein or in any document delivered pursuant hereto or waive compliance with any of the
agreements or conditions contained herein. Any agreement on the part of a party to any such extension or waiver shall be valid
only if set forth in an instrument in writing signed on behalf of such party. The failure of any party to this Agreement to assert
any of its rights under this Agreement or otherwise shall not constitute a waiver of such rights.

 

(d)
Procedure for Termination, Amendment, Extension or Waiver. A termination of this Agreement, an amendment of this Agreement
or an extension or waiver shall, in order to be effective, require in the case of VERTITEK or VMRI, action by its
respective Board of Directors or the duly authorized designee of such Board of Directors.

 

(signature
page follows)

 

    	12

    	 

    

 

In
witness whereof, the parties hereto have executed this Agreement concerning the exchange of securities on the dates noted below.

 

VERTITEK,
INC.

 

	By:	/s/
    Sean Foster	 
	 	Sean
    Foster, Sole Officer and Director	 

 

Date:
March 30, 2015

 

VALMIE
RESOURCES, INC.

 

	By:	/s/
    Gerald Hammack	 
	 	Gerald
    Hammack, Chairman and CEO	 

 

Date: March
30, 2015

 

MASAMOS
SERVICES LIMITED

 

	By:	/s/
    Dimitriy Protskiv	 
	 	Dimitriy Protskiv,
    Director	 

 

Date: March
27, 2015

 

    	13

    	 

    

  

EXHIBIT
1.1

 

SUBSCRIPTION
FOR SHARES

 

	TO:	Valmie
                                         Resources Inc. (the “Company”)

 

	AND TO:	The
                                         Sole Director Thereof

 

The
undersigned hereby subscribes for 1,000,000 shares of the Company’s common stock in exchange for 1,000,000 shares of Vertitek,
Inc. owned by the undersigned, pursuant to the Share Exchange Agreement by and between the Company, Vertitek, Inc. and the undersigned
to which this subscription for shares is attached.

Dated as
of March 31, 2015.

	MASAMOS
    SERVICES LIMITED	 
	 	 
	Per:	 
	 	 
	/s/
    Dimitriy Protskiv	 
	Dimitriy Protskivzmtp_ex43.htm

Exhibit 4.3

 

SUBSCRIPTION AND INFORMATION AGENT AGREEMENT

 

This Subscription and Information Agent Agreement (the “Agreement”) is entered into as of this 6th day of April 2015 by and between, Zoom Telephonics, Inc., organized and existing under the laws of Delaware (the “Corporation”), and Broadridge Corporate Issuer Solutions, Inc., a corporation having its principal offices in Philadelphia, Pennsylvania (“Broadridge”).

 

WHEREAS, pursuant to a rights offering (the “Rights Offering”), the record and beneficial holders of the Corporation’s common stock, par value $.01 per share (the “Common Stock”) will be given the right (the “Subscription Rights”) to subscribe for an aggregate of approximately 7,995,204 shares of Common Stock, in each case as more fully set forth in a prospectus and related offering documents (the “Offering Documents”) to be prepared by the Corporation and filed with the Securities and Exchange Commission for the purpose of effecting the Rights Offering; and

 

WHEREAS, the Corporation has authorized and directed the Agent to hold funds submitted by stockholders who exercise Subscription Rights (the “Subscription Funds”) in accordance with the terms and provisions of this Agreement; and

 

WHEREAS, upon the terms and conditions set forth in the applicable Offering Documents, the Agent will record properly exercised Subscription Rights from holders of the Common Stock on the Record Date (as defined in the applicable Offering Documents), as well as record and deposit the Subscription Funds for the purchase of the shares of Common Stock pursuant to the Rights Offering; and

 

WHEREAS, the Corporation desires that Broadridge act as both Subscription Agent and Information Agent under the Rights Offering (the “Agent”), and Broadridge has indicated its willingness to do so.

 

NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows:

 

1. Appointment of Subscription and Information Agent.  The Corporation hereby confirms the appointment of Broadridge as Agent, and Broadridge hereby agrees to serve as Agent, upon the terms and conditions set forth herein.

 

2. Acceptance and Receipt of Subscription Documents.

 

A. After receiving from the Corporation acknowledgement of the commencement of the Rights Offering, the Agent shall promptly mail to each holder of Common Stock as of the Record Date (a) the appropriate Offering Documents as approved by the Corporation (which shall specify that the exercise of Subscription Rights shall be effected, and risk of loss of Subscription Funds shall pass, only upon receipt by the Agent of the properly completed Subscription Certificate (as defined in the Offering Documents) and Subscription Funds required to effect the exercise of Subscription Rights under the Rights Offering) and (b) an envelope addressed to the Agent for use by such holder in exercising his or her Subscription Rights (the  “Mailing”).

 

  

1

  

 

           B.           The Agent, upon receipt of Subscription Funds and duly, completely and correctly executed Subscription Certificates and other documents for the exercise of Subscription Rights, shall make note of such Subscriptions and Subscription Funds with respect of the amount of shares subscribed for.  Upon closing of the Rights Offering and as promptly as feasible upon the Agent’s receipt of the Corporation’s acceptance and approval of said Subscription Certificates, (i) the Corporation will authorize the Agent to no longer accept any subscription documents and to prepare the final subscription list, representing the number of shares of Common Stock for which said stockholder has subscribed, for the issuance of stock certificates by the Corporation’s Transfer Agent, (the “Certificates”) and (ii) the Agent will release to the Corporation the aggregate Subscription Funds minus any fees and expense reimbursements (incurred or reserved for disbursements) due to the Agent from the Corporation (sections (i) and (ii) directly preceding constituting the “Closing”).  No interest on the Subscription Funds will accrue to either the Corporation or the Corporation’s stockholders.

3. Notification and Processing.  The Agent is hereby authorized and directed to, and hereby agrees to perform certain functions, including but not limited to the following:

 

A. Accept and respond to all telephone requests from stockholders for information relative to the exercise of Subscription Rights (except that Agent will not answer questions relating to the sufficiency of the consideration or the tax implications of the Rights Offering); answer questions regarding the proper method of exercising Subscription Rights, including the completion of Subscription Certificates and other documents related to the Rights Offering; maintain a toll-free number to respond to inquiries; provide assistance to holders of Common Stock and monitor the response to the Rights Offering; enclose and re-mail the Subscriptions to interested holders of Common Stock; and provide periodic reports as requested to the Corporation as to the status of the Rights Offering.

 

B. Date stamp each document relating to its duties hereunder when received;

 

C. Receive and examine all documents submitted to it in connection with the exercise of rights under the Rights Offering for proper execution in accordance with the terms thereof.  If Common Stock applicable to a subscription is held by more than one record holder, the applicable Offering Documents must be signed by each such holder; if a holder or joint holders (registrants) hold more than one position in the Corporation, as indicated by different accounts on the relevant record holder list, then separate, properly completed and executed subscriptions must be submitted for each such position held by that or those joint holders (registrants).

 

D. Retain or return to any holders (as applicable) those Offering Documents evidencing some deficiency in execution and make reasonable attempts to inform such holders of the need to correct any such deficiency; In any instance where the Agent cannot reconcile such deficiencies, the Agent shall consult with the Corporation for instructions as to whether the Agent may accept such exercise of Subscription Rights.  In the absence of such instructions by Corporation in writing or email within twenty-four (24) hours after Agent first requests such instructions, Agent is authorized not to accept such exercise of Subscription Rights and shall notify the exercising stockholder that its exercise is deficient;

 

  

2

  

 

E. Accept Subscription Certificates and other documents signed by persons acting in a fiduciary or representative capacity only if such capacity is properly shown on the subscriptions and proper evidence of their authority so to act has been submitted;

 

F. Accept subscriptions for Common Stock to be issued other than in the name that appears on the Corporation record stockholder list submitted for such subscription, where  (i) the signature thereon is guaranteed by a financial institution which is a participant in the Securities Transfer Agents Medallion Program (“STAMP”), the New York Stock Exchange, Inc. Medallion Signature Program (“MSP”), or The Stock Exchanges Medallion Program (“SEMP”), (ii) any necessary stock transfer taxes are paid and proof of such payment is submitted or funds therefore are provided to the Agent, or it is established by the holder that no such taxes are due and payable and (iii) the “Special Issuance Instructions” on the Subscription Certificate have been properly completed;

 

G. Retain all subscriptions accepted and retain such documents pending further instructions from the Corporation;

 

H. Return at the Corporation’s request any and all necessary records, information and material concerning and representing unsubscribed Common Stock under the Rights Offering; and

 

I. Maintain on a continuing basis a list of holders of Common Stock that have not yet subscribed pursuant to the Rights Offering.

 

4. Concerning the Subscription and Information Agent.

 

The Agent:

 

A. Shall have no duties or obligations other than those set forth herein, including those described under “Included Services” on Exhibit A, and no duties or obligations shall be inferred or implied, nor shall Agent be obligated nor expected to perform those services described under “Non-Included Services” on Exhibit A

 

B. May rely on, and shall be held harmless by, the Corporation in acting upon any certificate, statement, instrument, opinion, notice, letter, facsimile transmission, telegram electronic mail or other document, or any security delivered to it, and reasonably believed by it to be genuine and to have been made or signed by the proper party or parties;

 

C. May rely on and shall be held harmless by the Corporation in acting upon written or oral instructions from the Corporation with respect to any matter relating to its acting as Agent;

 

D. May consult on documents with counsel satisfactory to it (including counsel for the Corporation) and shall be held harmless by the Corporation in relying on the advice or opinion of such counsel in respect of any action taken, suffered or omitted by it hereunder in good faith and in accordance with such advice or opinion of such counsel;

 

  

3

  

E. Shall make the final determination as to whether or not a Subscription Certificate received by Agent is duly, completely and correctly executed in order to qualify for the Rights Offering and Agent shall be held harmless by the Corporation in respect of any action taken, suffered or omitted by Agent hereunder in good faith and in accordance with its determination; shall not be obligated to take any legal or other action hereunder which might, in its judgment subject or expose it to any expense or liability unless it shall have been furnished with an indemnity satisfactory to it;

 

F. Shall not be liable or responsible for any recital or statement contained in any Offering Document or any other documents relating thereto; and

 

G. Shall not be liable or responsible for any failure of the Corporation to comply with any of its obligations relating to the Offering, including without limitation obligations under applicable regulation or law.

 

This Agreement does not contemplate any service to be provided by Agent in the case where the conditions of the Rights Offering have not been met in a timely manner.  If necessary, service to be provided by Agent under such circumstances and remuneration to Agent therefore, will be established in a mutual agreement between Agent and the Corporation, which will become a part of this Agreement.

 

No later than the business day after the Mailing, the Corporation will provide Agent with a list of talking points dealing with anticipated questions from holders of Common Stock.  It is understood and agreed that Agent will not provide tax advice, will not interpret tax regulations, will not opine regarding the merits of the Rights Offering, and will not provide any comments related to any legal proceedings related to the Corporation.

 

5. Compensation of the Agent by the Corporation.

 

The Corporation shall pay fees for the services rendered hereunder, as set forth in the Fee Schedule (attached hereto as Exhibit A).  The Agent shall also be entitled to reimbursement from the Corporation for all reasonable and necessary expenses paid or incurred by it in connection with the administration by the Agent of its duties hereunder.  If for any reason the mailing for the rights offering does not occur, the Corporation will not pay fees. One half of the total Agent fees (not including postage) must be paid upon Corporation’s authorization for the mailing to occur.  The remaining half must be paid within fifteen (15) business days thereafter.  An invoice for any out-of-pocket and/or per item fees incurred will be rendered to and payable by the Corporation within fifteen (15) days of the date of said invoice, except for invoiced estimated postage, printing and mailing expenses, which funds must be received five (5) business days prior to the scheduled Mailing date.  It is understood and agreed that all responsibilities and duties of, and services to be performed by, Agent shall cease if full payment for its services has not been received in accordance with the above schedule, and said services will not commence thereafter until all payment due has been received by Agent.

 

6. Reminder Mailings.  The Corporation agrees that any follow up mailing program will be coordinated exclusively through Agent, either by Agent or using a vendor that Agent has previously approved.  Agent may conduct follow up mailings through electronic mail, to the extent the email address of the intended recipient Stockholder has been provided by Corporation to Agent.

 

  

4

  

7. Performance.

 

The Agent shall at all times act in good faith and agrees to use its commercially reasonable efforts within reasonable time limits to insure the accuracy and timeliness of all services performed under this Agreement.

 

8. Indemnification, Limitation of Liability.

 

A. The Corporation covenants and agrees to indemnify and to hold the Agent harmless against any claims, actions, judgments, liabilities, costs, expenses (including reasonable fees of its legal counsel), losses or damages, which may be paid, incurred or suffered by or to which it may become subject, arising from or out of its duties under this Agreement.  Promptly after the receipt by the Agent of notice of any demand or claim, or the commencement of any action, suit, proceeding or investigation, the Agent shall notify the Corporation thereof in writing.  The Corporation shall be entitled to participate at its own expense in the defense of any such claim or proceeding, and, if it so elects at any time after receipt of such notice, it may assume the defense of any suit brought to enforce any such claim or of any other legal action or proceeding.  Agent will not, without the Corporation’s prior consent, settle or compromise or consent to the entry of any judgment to any pending or threatened Action in respect of which indemnification may be sought hereunder.  For the purposes of this Section 8, the phrase “any costs, expenses (including reasonable fees of its legal counsel), losses or damages” means any amount paid or payable to satisfy any claim, demand, action, suit or proceeding settled, and all reasonable costs and expenses, including, but not limited to, reasonable counsel fees and disbursements, paid or incurred in investigating or defending against any such action, suit, proceeding or investigation.

 

B. Agent’s aggregate liability during any term of this Agreement with respect to, arising from, or arising in connection with this Agreement, or from all services provided or omitted to be provided under this Agreement, whether in contract, or in tort, or otherwise, is limited to, and shall not exceed, the amounts paid or payable hereunder by the Corporation to Agent as fees and charges, but not including reimbursable expenses.

 

C. In the event any question or dispute arises with respect to the proper interpretation of this Agreement or Agent’s duties hereunder or the rights of the Corporation or of any Stockholders exercising Subscription Rights, Agent shall not be required to act and shall not be held liable or responsible for refusing to act until the question or dispute has been judicially settled (and Agent may, if it deems it advisable, but shall not be obligated to, file a suit in interpleader or for a declaratory judgment for such purpose) by final judgment rendered by a court of competent jurisdiction, binding on all stockholders and parties interested in the matter which is no longer subject to review or appeal, or settled by a written document in form and substance satisfactory to Agent and executed by the Corporation and each such stockholder and party.  In addition, Agent may require for such purpose, but shall not be obligated to require, the execution of such written settlement by all the stockholders and all other parties that may have an interest in the settlement.

 

  

5

  

9. Further Assurance.  From time-to-time and after the date hereof, the Corporation shall deliver or cause to be delivered to the Agent such further documents and instruments and shall do and cause to be done such further acts as the Agent shall reasonably request (it being understood that the Agent shall have no obligation to make any such request) to carry out more effectively the provisions and purposes of this Agreement, to evidence compliance herewith or to assure itself that it is protected in acting hereunder.

 

10. Term.  The Corporation may terminate this Agreement at any time by providing 60 days written notification to the Agent.  The Agent may terminate this Agreement by providing the Corporation 60 days’ written notice, except that Agent may terminate this agreement at any time Corporation has not paid in full an invoice from the Agent within the time period described in section five (5) herein.  Upon the effective date of termination of this Agreement, all cash and other payments, without interest, and all other property then held by the Agent on behalf of the holders of Common Stock hereunder shall be delivered by it to such successor agent or as otherwise shall be designated in writing by the parties hereto.  Upon termination of this Agreement, all subscription documents received and related documentation will be returned to the Corporation.

 

11. Notices.  Until further notice in writing by either party hereto to the other party, all written reports, notices and other communications between the Agent and the Corporation required or permitted  hereunder shall be delivered or mailed by first class mail, postage prepaid, addressed as follows:

 

	
If to the Corporation, to:

	  
	  	
Attn: Kerry Smith or Frank Manning

Zoom Telephonics

207 South Street

Boston, MA 02111

 

	
If to the Agent, to:

	
Broadridge Corporate Issuer Solutions, Inc.

1717 Arch Street, Suite 1300

Philadelphia, PA 19103

Attn:  Re-Organization Department

12. Governing Law.  This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania and shall inure to the benefit of, and the obligations created hereby shall be binding upon, the successors and assigns of the parties hereto.

 

13. Assignment.

 

A. Except as provided in Section 13(B) below, neither this Agreement nor any rights or obligations hereunder may be assigned by either party without the written consent of the other party.

 

  

6

  

B. The Agent may, without further consent on the part of the Corporation, subcontract with subcontractors for systems, processing, telephone and mailing services, and reminder mailing activities, as may be required from time to time; provided, however, that the Agent shall be fully responsible to the Corporation for the acts and omissions of any subcontractor.

 

C. Except as explicitly stated elsewhere in this Agreement, nothing under this Agreement shall be construed to give any rights or benefits in this Agreement to anyone other than the Agent and the Corporation and the duties and responsibilities undertaken pursuant to this Agreement shall be for the sole and exclusive benefit of the Agent and the Corporation.  This Agreement shall inure to the benefit of and be binding upon the parties and their respective permitted successors and assigns.

 

14. Amendment.  This Agreement may not be modified, amended or supplemented without an express written agreement executed by each of the parties hereto.

 

15. Counterparts.  This Agreement may be executed in separate counterparts, each of which, when executed and delivered, shall be an original, but all such counterparts shall together constitute but one and the same instrument.

 

16. No Joint Venture.  This Agreement does not constitute an agreement for a partnership or joint venture between the Agent and the Corporation.  Neither party shall make any commitments with third parties that are binding on the other party without the other party’s prior written consent.

 

17. Force Majeure.  In the event either party is unable to perform its obligations under the terms of this Agreement because of acts of God, strikes, equipment or transmission failure or damage that is reasonably beyond its control, or other cause that is reasonably beyond its control (except, in the case of the Agent, for acts of subcontractors), such party shall not be liable for damages to the other for any damages resulting from such failure to perform or otherwise from such causes.  Performance under this Agreement shall resume when the affected party or parties are able to perform substantially that party’s duties.

 

18. Consequential Damages.  Neither party to this Agreement shall be liable for any consequential, indirect, special or incidental damages under any provision of this Agreement or for any consequential, indirect, penal, special or incidental damages arising out of any act or failure to act hereunder even if that party has been advised of or has foreseen the possibility of such damages.

 

19. Severability.  If any provision of this Agreement shall be held invalid, unlawful, or unenforceable, the validity, legality, and enforceability of the remaining provisions shall not in any way be affected or impaired.

 

20. Confidentiality.  The Agent and the Company agree that all books, records, information and data pertaining to the business of the other party which are exchanged or received pursuant to the negotiation or the carrying out of this Agreement, including the fees for services set forth in the attached schedule, shall remain confidential and shall not be voluntarily disclosed to any third party (except the party’s attorneys, advisors and affiliates), except with the written approval of the other party or as may be required by law or regulatory authority.

 

  

7

  

21. Survival.  The provisions of Sections 4, 5, 6, 8, 9, 11, 12, 13, 18, 20, 21 and 22 shall survive any termination of this Agreement.

 

22. Merger of Agreement.  This Agreement constitutes the entire agreement between the parties hereto and supersedes any prior agreement with respect to the subject matter hereof whether oral or written.

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their respective officers, hereunto duly authorized, as of the day and year first above written.

 

	
BROADRIDGE CORPORATE ISSUER SOLUTIONS, INC.

	
ZOOM TELEPHONICS, INC.

	
By:           /s/  John Dunn

	
By: /s/ Frank Manning

	
Title:Vice President of Sales

	
Title:President and CEO

  

8

  

 

Exhibit A

 

AGENT FEES AND INCLUDED SERVICES

 

Subscription and Information Agent Fee of $$3,750.00, plus $10.00 for each line item on Depository Trust Company's ATOP forms submitted to Agent.

 

Agent shall be entitled to reimbursement of all reasonable out-of-pocket expenses including but not limited to postage, stationery and supplies, which will be billed as incurred during the performance of Agent’s duties hereunder, including without limitation:

 

Out of pocket expenses

 

	
●  

	
Postage with shared Pre-Sort savings (to be paid in advance) 1

	
●  

	
Overnight delivery / courier service / photocopy service

	
●  

	
Envelopes – outer and BRE (Business Reply Envelopes) 1

	
●  

	
Brochures and enrollment materials

	
●  

	
Insurance and courier fees

	
●  

	
Printing of check forms and blank stock certificates

Although Agent may advance payment for these expenses and then invoice Company, there are occasions when Agent may require advance payment toward large expense items.

INCLUDED SERVICES

 

	
●  

	
Designating a corporate action account manager to communicate with all parties hereto and their counsel to establish the terms, timing  and procedures required  to carry out Subscription  Agent duties, including document review and execution of legal agreements, Subscription Certificates and other Rights Offering documents and communication materials, project management, and on-going project updates and reporting.

 

	
●  

	
Designating an Information Agent account manager to review and become familiar with all Offer Documents and provide expert assistance to holders of Common Stock related to matters concerning the Rights Offering.

 

	
●  

	
Preparing labels that include name, address for the mailing of Offering Documents.

 

	
●  

	
Collating and assembling Offering Documents and envelopes for mailing.

 

	
●  

	
Addressing and enclosing Offering Documents and return envelopes, for one-time, one-day mailing to holders of Common Stock.

 

	
●  

	
Receiving, opening and logging in returned Subscription Certificates.

 

1 Rates are subject to change upon U.S. and foreign postage rate increases.

  

9

  

 

 

	
●  

	
Checking Subscription Certificates for validity against master list.

 

	
●  

	
Checking for proper execution of all of Subscription Certificates and other documents necessary to effect a proper exercise of Subscription Rights, including W-9’s (if applicable).

 

	
●  

	
Curing defective subscriptions, including telephoning and writing holders of Common Stock in connection with unsigned or improperly executed Subscription Certificates and other Offering Documents.

 

	
●  

	
Soliciting by mail W-9’s from holders of Common Stock who have not executed them or whose TIN’s do not match our records.

 

	
●  

	
Tracking and reporting as required the number of shares of Common Stock to which stockholders have subscribed.

 

	
●  

	
Sealing, addressing, posting (not including postage), and providing envelopes for mailing to holders of Common Stock.

 

	
●  

	
Providing stockholder relations services to all holders of Common Stock related to the Rights Offering, including phone, email, and regular mail inquiries.

 

NON-INCLUDED SERVICES

 

	
●  

	
Services associated with new duties, legislation or regulations which become effective after the date of this Agreement (these will be provided on an appraisal basis)

 

	
●  

	
Reasonable legal review fees if referred to outside counsel

 

	
●  

	
Overtime charges at 100% assessed in the event of late delivery of material for mailings, unless the target mail date is rescheduled

 

	
●  

	
Dedicated Toll Free 800 Number

 

10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}]]